Acasti Pharma Inc. reported unaudited earnings results for the third quarter and year to date ended of November 30, 2015. For the quarter, the company's Adjusted LBITDA was CAD 1,988,000 for the quarter, against CAD 2,099,000 in the prior year. Net loss was CAD 2,191,000 for the quarter, against net earnings of CAD 3,012,000 in the prior year. Revenue from sales was CAD 5,074 compared to CAD 28,816 a year ago. Basic and diluted loss per share was CAD 0.21 compared to basic and diluted earnings per share of CAD 0.28 a year ago. Book value per Class A share was CAD 2.72 compared to CAD 3.33 a year ago. Net cash used in operating activities was CAD 1,629,344 compared to CAD 2,230,129 for the same period a year ago. The decrease in cash flows from operating activities for the three-month periods ended November 30, 2015 is mainly attributable to a lower net loss incurred after adjustments for non-cash items and changes in non-cash working capital items. Loss from operations was CAD 2,633,379 compared to CAD 2,964,530 a year ago. Addition of intangible assets was CAD 46,320 compared to CAD 19,337 a year ago. Acquisition of equipment was CAD 79,239.

For the year to date, the company's Adjusted LBITDA was CAD 5,418,000 for the current year-to-date, against CAD 6,244,000 in the prior year. Net loss was CAD 4,398,000, against net earnings of CAD 656,000 in the prior year. Revenue from sales was CAD 17,227 compared to CAD 92,428 a year ago. Basic and diluted loss per share was CAD 0.41 compared to basic and diluted earnings per share of CAD 0.06 a year ago. Net cash used in operating activities was CAD 4,883,149 compared to CAD 4,575,276 for the same period a year ago. The decrease in cash flows from operating activities for the nine-month periods ended November 30, 2015 and 2014 is mainly attributable to a higher net loss incurred after adjustments for non-cash items and changes in non-cash operating working capital. Loss from operations was CAD 7,402,510 compared to CAD 9,390,536 a year ago. Addition of intangible assets was CAD 83,645 compared to CAD 41,303 a year ago. Acquisition of equipment was CAD 222,565 compared to CAD 34,650 a year ago.